Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Current Medicinal Chemistry|October 13, 2017
Pharmacological Targeting of Neuronal Kv7.2/3 Channels: A Focus on Chemotypes and Receptor SitesFrancesco Miceli, Maria V Soldovieri, Paolo Ambrosino, et al.
Channels (Austin, Tex.)|August 14, 2008
Correlating the clinical and genetic features of benign familial neonatal seizures (BFNS) with the functional consequences of underlying mutationsMaria Virginia Soldovieri, Francesco Miceli, Giulia Bellini, et al.
Cell Death Discovery|September 20, 2022
A new K+channel-independent mechanism is involved in the antioxidant effect of XE-991 in an in vitro model of glucose metabolism impairment: implications for Alzheimer's diseaseSilvia Piccirillo, Alessandra Preziuso, Salvatore Amoroso, et al.
Biophysical Journal|June 3, 2008
Gating consequences of charge neutralization of arginine residues in the S4 segment of K(v)7.2, an epilepsy-linked K+ channel subunitFrancesco Miceli, Maria Virginia Soldovieri, Ciria C Hernandez, et al.
Frontiers in Cellular Neuroscience|August 4, 2015
Molecular pathophysiology and pharmacology of the voltage-sensing module of neuronal ion channelsFrancesco Miceli, Maria Virginia Soldovieri, Paolo Ambrosino, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 27, 2013
Genotype-phenotype correlations in neonatal epilepsies caused by mutations in the voltage sensor of K(v)7.2 potassium channel subunitsFrancesco Miceli, Maria Virginia Soldovieri, Paolo Ambrosino, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 6, 2015
Early-onset epileptic encephalopathy caused by gain-of-function mutations in the voltage sensor of Kv7.2 and Kv7.3 potassium channel subunitsFrancesco Miceli, Maria Virginia Soldovieri, Paolo Ambrosino, et al.
Epilepsia|April 28, 2025
Potassium current inactivation as a novel pathomechanism for KCNQ2 developmental and epileptic encephalopathyIngride Luzio Gaspar, Gaetano Terrone, Giusy Carleo, et al.
Clinical Pharmacology : Advances and Applications|February 1, 2012
Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabineVincenzo Barrese, Francesco Miceli, Maria Virginia Soldovieri, et al.
Molecular Pharmacology|September 11, 2013
Subtype-selective activation of K(v)7 channels by AaTXKβ₂₋₆₄, a novel toxin variant from the Androctonus australis scorpion venomZied Landoulsi, Francesco Miceli, Angelo Palmese, et al.
Pageof 6